Peritoneal Metastases of Colorectal Cancer
Peritoneal metastases of colorectal cancer occur when cancer cells from the colon or rectum spread to the peritoneum, leading to serious complications and requiring specialized treatment.
Colon Cancer: HIPEC with Mitomycin-C Study
We are investigating whether adding a special chemotherapy during surgery helps prevent cancer recurrence in patients with colon cancer that has spread to the abdomen. This study compares outcomes for those receiving this treatment versus standard care.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have colon cancer that is not signet ring cell type?
- Are you currently pregnant or breastfeeding?
- Have you had any other cancers in the last 5 years, except for skin cancer?
- Have you received treatment for cancer in the past, such as chemotherapy?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Mitameta
Mitem
Mito-Extra
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Principe De Asturias
Cirugía
Alcalá de Henares, Spain
Hospital Universitario Fundacion Alcorcon
Cirugía
Alcorcón, Spain
Hospital Universitario Torrecardenas
Cirugía
Almería, Spain
Sponsor: Hospital Universitario De Fuenlabrada
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.